{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:49:06Z","timestamp":1791474546540,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.humpath.2015.05.017","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T15:09:28Z","timestamp":1433603368000},"page":"1350-1359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9743-7265","authenticated-orcid":false,"given":"Semir","family":"Vranic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Marchi\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Stella","family":"Scalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Payan-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica Verdun","family":"di Cantogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Gugliotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Tondat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Francia","family":"di Celle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Gatalica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sapino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2015.05.017_bb0005","first-page":"1393","article-title":"Apocrine carcinoma of the breast: a comprehensive review","volume":"28","author":"Vranic","year":"2013","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0010","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/sj.onc.1208561","article-title":"Identification of molecular apocrine breast tumours by microarray analysis","volume":"24","author":"Farmer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2015.05.017_bb0015","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1038\/sj.onc.1209415","article-title":"An estrogen receptor\u2013negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen","volume":"25","author":"Doane","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2015.05.017_bb0020","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/bcr1771","article-title":"Gene expression profiling and histopathological characterization of triple-negative\/basal-like breast carcinomas","volume":"9","author":"Kreike","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.humpath.2015.05.017_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1755-8794-2-59","article-title":"Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family","volume":"2","author":"Sanga","year":"2009","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.humpath.2015.05.017_bb0030","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/onc.2011.301","article-title":"A refined molecular taxonomy of breast cancer","volume":"31","author":"Guedj","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2015.05.017_bb0035","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ijc.27767","article-title":"Distinct tumor protein p53 mutants in breast cancer subgroups","volume":"132","author":"Dumay","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2015.05.017_bb0040","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/bcr3421","article-title":"Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15","volume":"15","author":"Lehmann-Che","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.humpath.2015.05.017_bb0045","first-page":"1083","article-title":"Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2\/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast","volume":"12","author":"Lininger","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-9440(10)63959-4","article-title":"Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast","volume":"158","author":"Jones","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/modpathol.2010.50","article-title":"EGFR and HER-2\/neu expression in invasive apocrine carcinoma of the breast","volume":"23","author":"Vranic","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0060","doi-asserted-by":"crossref","first-page":"e75193","DOI":"10.1371\/journal.pone.0075193","article-title":"A collection of primary tissue cultures of tumors from vacuum packed and cooled surgical specimens: a feasibility study","volume":"8","author":"Annaratone","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2015.05.017_bb0065","doi-asserted-by":"crossref","first-page":"907","DOI":"10.5858\/134.6.907","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2015.05.017_bb0070","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/his.12066","article-title":"Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study","volume":"62","author":"Rakha","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2015.05.017_bb0075","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/modpathol.2009.16","article-title":"Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact","volume":"22","author":"Sangoi","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2559.2007.02638.x","article-title":"Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression","volume":"50","author":"Rakha","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2015.05.017_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4161\/cbt.10.2.11983","article-title":"Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers","volume":"10","author":"Witkiewicz","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.humpath.2015.05.017_bb0090","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/PAI.0b013e318206d23d","article-title":"Proliferation (Ki-67 and phosphohistone H3) and oncotype DX recurrence score in estrogen receptor-positive breast cancer","volume":"19","author":"Williams","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.2407","article-title":"Refinement of breast cancer classification by molecular characterization of histological special types","volume":"216","author":"Weigelt","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.2574","article-title":"Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis","volume":"219","author":"Marchi\u00f2","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"138","author":"Wolff","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2015.05.017_bb9000","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2015.05.017_bb0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/modpathol.2009.136","article-title":"Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer","volume":"23","author":"Moelans","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/bcr3146","article-title":"To bind or not to bind\u2014FoxA1 determines estrogen receptor action in breast cancer progression","volume":"14","author":"Watters","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.humpath.2015.05.017_bb0125","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1038\/onc.2013.308","article-title":"Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells","volume":"33","author":"Raina","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2015.05.017_bb0130","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/annonc\/mdt162","article-title":"Evaluation of mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer","volume":"24","author":"Sinn","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0135","first-page":"146","article-title":"The HER2 amplicon in breast cancer: topoisomerase IIA and beyond","volume":"2013","author":"Jacot","year":"1836","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2015.05.017_bb0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cas.12121","article-title":"Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation","volume":"104","author":"McNamara","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2015.05.017_bb0145","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/ijc.28315","article-title":"Loss of heterozygosity at 13q13 and 14q32 predicts BRCA2 inactivation in luminal breast carcinomas","volume":"133","author":"P\u00e9cuchet","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2015.05.017_bb0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/gcc.22037","article-title":"The 11q13-q14 amplicon: clinicopathological correlations and potential drivers","volume":"52","author":"Wilkerson","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2015.05.017_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/emmm.201100121","article-title":"ZNF703 gene amplification at 8p12 specifies luminal B breast cancer","volume":"3","author":"Sircoulomb","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.humpath.2015.05.017_bb0160","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ijc.11161","article-title":"Expression of ADAM-9 mRNA and protein in human breast cancer","volume":"105","author":"O\u2019Shea","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2015.05.017_bb0165","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/modpathol.2013.94","article-title":"Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification","volume":"26","author":"Lacle","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.05.017_bb0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1535-7163.MCT-12-0781","article-title":"Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities","volume":"12","author":"Craig","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.humpath.2015.05.017_bb0175","doi-asserted-by":"crossref","first-page":"e60576","DOI":"10.1371\/journal.pone.0060576","article-title":"Prognostic and predictive significance of MYC and KRAS alterations in breast cancer from women treated with neoadjuvant chemotherapy","volume":"8","author":"Pereira","year":"2013","journal-title":"PLoS One"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715001938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715001938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T11:25:37Z","timestamp":1717932337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817715001938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0046817715001938"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2015.05.017","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2015.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}